This site is intended for healthcare professionals only
LoginRegister

Oncology Dialogues

Bristol Myers Squibb, BioNTech ink pact

Bristol Myers Squibb, BioNTech ink pact to co-develop, co-commercialize investigational bispecific...

Princeton: BioNTech SE and Bristol Myers Squibb have announced that the companies have entered into an agreement for the global...
View All

Latest News and Guidelines

Study Unveils Protein That May Be Responsible for Spread of Pancreatic Cancer

Study Unveils Protein That May Be Responsible for Spread of Pancreatic Cancer

Novartis concludes acquisition of Regulus Therapeutics

Zydus Lifesciences to acquire India, Sri Lanka rights for Agenus cancer immunotherapy BOT/BAL

Dr Reddys Labs, Alvotech ink pact to codevelop biosimilar candidate to Keytruda

Cancer drug: Dr Reddy's Labs, Alvotech ink pact to codevelop biosimilar candidate to Keytruda

Nrf2 identified as a key driver of treatment resistance in osteosarcoma: Study

Nrf2 identified as a key driver of treatment resistance in osteosarcoma: Study

Exercise Cuts Cancer Death Risk by Over a Third: Study Finds

Exercise Cuts Cancer Death Risk by Over a Third: Study Finds

Therapeutic Thoracentesis Adds No Benefit Over Diuretics in Acute Heart Failure with Pleural Effusion: Study

Therapeutic Thoracentesis Adds No Benefit Over Diuretics in Acute Heart Failure with Pleural...

View All
X